Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 3, keine Gesamtzahl für „Xenleta“
Suchtreffer
Begriffe & Kennungen
Xenleta · 4.5 · Co-administration of lefamulin with sensitive CYP2C8 substrates such as repaglinide may result in increased pl
Eintrag öffnenXenleta · 4.5 · Co-administration of oral lefamulin with medicinal products metabolised by CYP3A such as alprazolam, alfentani
Eintrag öffnenXenleta · 4.5 · Co-administration with other medicinal products known to prolong the QT interval is contraindicated (see secti
Eintrag öffnenXenleta · 4.5 · Effects of other products on lefamulin
Eintrag öffnenXenleta · 4.5 · In a clinical drug-drug interaction study, no clinically relevant interaction was observed when lefamulin was
Eintrag öffnenXenleta · 4.5 · In a clinical drug-drug interaction study, no clinically relevant interaction was observed when lefamulin was
Eintrag öffnenXenleta · 4.5 · Lefamulin is a moderate CYP3A inhibitor but has no induction potential.
Eintrag öffnenXenleta · 4.5 · Pharmacodynamic interactions
Eintrag öffnenXenleta · 4.5 · Pharmacodynamic interactions
Eintrag öffnenXenleta · 4.5 · Pharmacokinetic interactions
Eintrag öffnenXenleta · 4.5 · Pharmacokinetic interactions
Eintrag öffnenXenleta · 4.5 · Potential for lefamulin to affect other medicinal products
Eintrag öffnenXenleta · 4.5 · Potential for lefamulin to affect other medicinal products
Eintrag öffnenXenleta · 4.5 · Table 2 summarises effects on plasma concentrations of lefamulin and on co-administered medicinal products exp
Eintrag öffnenXenleta · 4.5 · Table 2 summarises effects on plasma concentrations of lefamulin and on co-administered medicinal products exp
Eintrag öffnenXenleta · 4.5 · Table 2: Interactions and dose recommendations of intravenous Xenleta with other medicinal products Medicinal
Eintrag öffnenXenleta · 4.5 · Table 2: Interactions and dose recommendations of oral Xenleta with other medicinal products Medicinal product
Eintrag öffnenXenleta · 4.5 · Use with moderate and strong CYP3A/P-gp inducers Medicinal products that are moderate or strong CYP3A inducers
Eintrag öffnenXenleta · 4.5 · Use with moderate and strong CYP3A/P-gp inducers Medicinal products that are moderate or strong CYP3A inducers
Eintrag öffnenXenleta · 4.6 Fertility, pregnancy and lactation · 1
Eintrag öffnen